Outset Medical adjusts stockholder voting rules
Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a significant amendment to its corporate bylaws affecting how stockholder votes are tallied for company decisions.
Outset Medical price target lowered to $3 from $4 at BTIG
BTIG lowered the firm’s price target on Outset Medical (OM) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model
Outset Medical Inc (OM) Stock Price Reaches $0.98: What Factors Are Influencing This Level?
On Wednesday, Outset Medical Inc (OM) stock saw a decline, ending the day at $0.98 which represents a decrease of $-0.12 or -10.91% from the prior close of $1.1. The stock opened at $1.15 and touched a low of $0.83 during the day, reaching a high of $1.15. The volume of shares traded was 3.14 million exceeding the average volume of 0.90 million.
BTIG cuts Outset Medical target to $3, maintains Buy rating
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease from the previous $4.00, while continuing to recommend a Buy rating for the stock.
Inspire Medical price target lowered to $234 from $236 at KeyBanc
KeyBanc lowered the firm’s price target on Inspire Medical (INSP) to $234 from $236 and keeps an Overweight rating on the shares after the
Outset Medical Inc (OM) Stock Trading Recap
On Wednesday, Outset Medical Inc (OM) stock saw a decline, ending the day at $0.76 which represents a decrease of $-0.05 or -6.17% from the prior close of $0.81. The stock opened at $0.83 and touched a low of $0.71 during the day, reaching a high of $0.83. The volume of shares traded was 1.87 million exceeding the average volume of 1.03 million.
KeyBanc cuts Inspire Medical stock target to $234
KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision follows Inspire Medical (TASE:PMCN)'s pre-announcement of its fourth-quarter results and initial guidance for the year 2025.
Nasdaq19d
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...
ETF Daily News20d
Outset Medical Announces Private Placement Financing and New Debt Agreement
Outset Medical, Inc. (NASDAQ: OM) revealed, in an 8-K form filed on January 3, 2025, several significant financial transactions. The company entered into securities purchase agreements for the ...
Analysts Are Bullish on Top Healthcare Stocks: Gilead Sciences (GILD), Outset Medical (OM)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...
Nasdaq19d
Outset Medical Secures New Financing and Debt Facility
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Yahoo Finance17d
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
Investing17d
Outset Medical issues Series A Preferred Stock, repays senior credit
SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company with a market capitalization of $52 million, announced the closure of a private placement offering and the ...